These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34858331)

  • 61. Thymoquinone suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation, migration and neointimal formation.
    Zhu N; Xiang Y; Zhao X; Cai C; Chen H; Jiang W; Wang Y; Zeng C
    J Cell Mol Med; 2019 Dec; 23(12):8482-8492. PubMed ID: 31638340
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation.
    Liu D; Wu M; Du Q; Ding Z; Qian M; Tong Z; Xu W; Zhang L; Chang H; Wang Y; Huang C; Lin D
    J Cell Mol Med; 2017 Dec; 21(12):3810-3820. PubMed ID: 28767201
    [TBL] [Abstract][Full Text] [Related]  

  • 63. BOP1 Knockdown Attenuates Neointimal Hyperplasia by Activating p53 and Inhibiting Nascent Protein Synthesis.
    Jia F; Wu Q; Wang Z; Zhang M; Yuan S; Che Y; Li B; Hu Z; Hu X
    Oxid Med Cell Longev; 2021; 2021():5986260. PubMed ID: 33510838
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.
    Tan J; Yang L; Liu C; Yan Z
    Sci Rep; 2017 Apr; 7():46602. PubMed ID: 28429763
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
    Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
    Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PPARγ Inhibits VSMC Proliferation and Migration via Attenuating Oxidative Stress through Upregulating UCP2.
    Zhou Y; Zhang MJ; Li BH; Chen L; Pi Y; Yin YW; Long CY; Wang X; Sun MJ; Chen X; Gao CY; Li JC; Zhang LL
    PLoS One; 2016; 11(5):e0154720. PubMed ID: 27144886
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
    Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumor Necrosis Factor Receptor-Associated Factor 5 Promotes Arterial Neointima Formation through Smooth Muscle Cell Proliferation.
    Willecke F; Rupprecht B; Gissler MC; Pfeiffer K; Anto-Michel N; Stachon P; Wolf D; Hilgendorf I; Hoppe N; Bode C; Zirlik A
    J Vasc Res; 2019; 56(6):308-319. PubMed ID: 31437850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathological Role of Phosphoglycerate Kinase 1 in Balloon Angioplasty-Induced Neointima Formation.
    Pan CH; Chien YC; Sung MS; Huang HY; Sheu MJ; Wu CH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445528
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
    Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
    Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Choe N; Kwon JS; Kim JR; Eom GH; Kim Y; Nam KI; Ahn Y; Kee HJ; Kook H
    Atherosclerosis; 2013 Aug; 229(2):348-55. PubMed ID: 23880186
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation.
    Wang YS; Wang HY; Liao YC; Tsai PC; Chen KC; Cheng HY; Lin RT; Juo SH
    Cardiovasc Res; 2012 Sep; 95(4):517-26. PubMed ID: 22802111
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
    Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
    Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes injury-induced vascular neointima formation in mice.
    Guo S; Zhang R; Liu Q; Wan Q; Wang Y; Yu Y; Liu G; Shen Y; Yu Y; Zhang J
    FASEB J; 2019 Sep; 33(9):10207-10217. PubMed ID: 31216422
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decreasing mitochondrial fission diminishes vascular smooth muscle cell migration and ameliorates intimal hyperplasia.
    Wang L; Yu T; Lee H; O'Brien DK; Sesaki H; Yoon Y
    Cardiovasc Res; 2015 May; 106(2):272-83. PubMed ID: 25587046
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated with increased C/EBP homologous protein expression.
    Serrano RL; Yu W; Terkeltaub R
    Atherosclerosis; 2014 Apr; 233(2):493-502. PubMed ID: 24530784
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAPM/PKA/mTORC1/rpS6 Pathway.
    Xu H; Fang B; Bao C; Mao X; Zhu C; Ye L; Liu Q; Li Y; Du C; Qi H; Zhang X; Guan Y
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078128
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
    J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suv39h1 downregulation inhibits neointimal hyperplasia after vascular injury.
    Zhang J; Chen J; Yang J; Xu C; Hu Q; Wu H; Cai W; Guo Q; Gao W; He C; Yang C; Yang J
    Atherosclerosis; 2019 Sep; 288():76-84. PubMed ID: 31330382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.